NCT05935748 2025-11-12Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)NiKang Therapeutics, Inc.Phase 2 Terminated18 enrolled
NCT02307487 2017-06-16Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC PatientsUroGen Pharma Ltd.Phase 2 Completed14 enrolled